← Leaderboards
Steven W Millward
University Of Tx Md Anderson Can Ctr
$2,960,608
Attributed
$4,153,508
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,153,508 · 4
By mechanism
R44$2,003,000 · 1
R01$1,618,674 · 1
R21$382,800 · 1
F32$149,034 · 1
Top collaborators
- Stephen Fiacco3 shared
- Zhen Lu2 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Wendy A Woodward$3,444,065
- Florian Muller$1,610,887
- Ken H. Young$1,790,016
- Kathleen Marie Schmainda$14,483,193
- Bisrat G Debeb$834,216
Others in their field
Top investigators on “Specificity”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Eric S Lander · Whitehead Institute For Biomedical Res$527,312,131
- Barton F Haynes · Duke University$483,626,898
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$395,980,920
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$381,706,339
Research focus
SpecificityMalignant NeoplasmsMouse ModelDesignTumorDosePharmaceutical PreparationsProtein IsoformsMolecularTissuesSafetyPrecision MedicineLeadToxic EffectCancer PatientSmall MoleculeEventSignal TransductionBiologicalLiverMetabolismNormal Tissue MorphologyPermeabilityMetabolic
Grant awards (13)
Pro-Drug Enolase Inhibitors in Precision Oncology$329,668
R01 · FY2025 · CA · contact PI
Pro-Drug Enolase Inhibitors in Precision Oncology$313,186
R01 · FY2024 · CA · contact PI
Pro-Drug Enolase Inhibitors in Precision Oncology$323,076
R01 · FY2023 · CA · contact PI
Pro-Drug Enolase Inhibitors in Precision Oncology$323,076
R01 · FY2022 · CA · contact PI
Pro-Drug Enolase Inhibitors in Precision Oncology$329,668
R01 · FY2021 · CA · contact PI
Development of SUPR peptides as PET Imaging Agents for Her2+ Breast Cancer$3,090
R44 · FY2018 · CA
Development of SUPR peptides as PET Imaging Agents for Her2+ Breast Cancer$1,144,342
R44 · FY2017 · CA
Targeted Molecular Imaging of Cell Death in Ovarian Cancer$208,800
R21 · FY2017 · CA · contact PI
Development of SUPR peptides as PET Imaging Agents for Her2+ Breast Cancer$855,568
R44 · FY2016 · CA
Targeted Molecular Imaging of Cell Death in Ovarian Cancer$174,000
R21 · FY2016 · CA · contact PI
Design of Affinity Capture Agents for Akt1 Using in situ Click Chemistry$52,154
F32 · FY2010 · CA · contact PI
Design of Affinity Capture Agents for Akt1 Using in situ Click Chemistry$50,054
F32 · FY2009 · CA · contact PI
Design of Affinity Capture Agents for Akt1 Using in situ Click Chemistry$46,826
F32 · FY2008 · CA · contact PI